Health condition
Smouldering myeloma
Smouldering myeloma sits between MGUS and active myeloma: the plasma cell clone is larger, but there is still no organ damage; most patients are monitored closely, with treatment reserved for those crossing defined thresholds.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Defined by higher paraprotein levels or marrow plasma cells than MGUS, without organ damage
-
Progression risk is front-loaded - highest in the first five years after diagnosis
-
Risk models (such as 20/2/20) identify patients needing closer surveillance
-
Standard care in the UK remains monitoring; trials of early treatment are ongoing
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
Smouldering myeloma is usually discovered when MGUS-type investigations reveal a larger disease burden than expected: a paraprotein above 30 g/L or marrow plasma cells above 10%, but with normal calcium, kidneys, haemoglobin and bones. It is a waiting-room diagnosis in the literal sense - some patients progress to myeloma within a few years, while others remain stable indefinitely.
Diagnosis and treatment routes
Modern assessment leans on risk models combining paraprotein level, free light chain ratio and marrow burden, plus whole-body imaging to exclude hidden bone disease. High-risk smouldering myeloma is monitored intensively, typically every two to three months at first, and is the group where clinical trials of early intervention are most relevant - worth asking about if this is your diagnosis. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant haematologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Smouldering myeloma.
Quick, plain-English answers to what people ask us most.
-
What does smouldering myeloma mean?
Smouldering myeloma is a term used for a cancer or cancer-related condition affecting a specific tissue or organ. The exact nature, behaviour and severity vary from person to person, which is why diagnosis and staging by a specialist team are essential.
-
What are the risk factors for smouldering myeloma?
The exact cause is often not fully understood, though risk can be influenced by a combination of genetic factors, age, lifestyle factors, and in some cases exposure to specific triggers. Many people affected have no identifiable single cause.
-
What are the symptoms of smouldering myeloma?
Symptoms depend on where it is and how advanced it is, and can include a new lump, unexplained pain, unexpected weight loss, fatigue, or changes specific to the affected area. Some cases are picked up incidentally on scans before symptoms appear.
-
How worried should I be about smouldering myeloma?
This depends heavily on the type, stage and how it responds to treatment — some cases are highly treatable, especially when caught early, while others need more intensive management. Your oncology team will give you a personalised assessment rather than a generic answer.
-
Is smouldering myeloma hereditary or genetic?
This depends on the specific condition — some cases have a genetic or familial component, while others are linked more to environmental, lifestyle or other health factors. If you have a relevant family history, it's worth mentioning to your clinician.
-
Is there a cure for smouldering myeloma?
Outcomes depend on the type and stage, but many cases respond well to treatment, particularly when identified early. "Cure" isn't always the right framing for every case — your team will discuss realistic goals, whether that's cure, remission, or long-term control.
-
How is smouldering myeloma treated?
Treatment is tailored to the type and stage, and may include surgery, radiotherapy, chemotherapy, targeted or immunotherapy, or a combination, decided by a multidisciplinary specialist team.
-
What is the long-term outlook for smouldering myeloma?
This varies significantly by type and stage, and your specialist team will give you a personalised sense of prognosis and expected timelines for treatment and follow-up rather than a general figure.
-
When should specialist referral be considered for smouldering myeloma?
Specialist referral is appropriate as soon as this is suspected or confirmed, so that staging and a treatment plan can begin without delay — earlier specialist input generally supports better outcomes.
-
When should I see a doctor about smouldering myeloma, and how quickly can I be seen privately?
See a doctor if symptoms are persistent, worsening, or affecting your daily life — earlier assessment generally leads to better management. NHS routine referrals for this kind of concern often take 20–45 weeks or longer depending on the area, while a private consultant can typically see you within about 2 weeks, with faster access to scans and specialist opinion.